PRESS STATEMENTS03.24.2017 Pfizer and the National Newspaper Publishers Association Collaborate to Raise Awareness of Sickle Cell Disease and Need for Improved Patient Care03.13.2017 European League Against Rheumatism (EULAR) Includes Janus Kinase (JAK) Inhibitors in Updated Recommendations for the Management of RA11.07.2016 VYNDAQEL® (tafamidis) Receives Approval in Brazil by ANVISA for the Treatment of Transthyretin Familial Amyloid Polyneuropathy07.05.2016 Pfizer Showcases 12 New Data Presentations On Transthyretin Amyloidosis, Increasing Understanding Of A Rare Disease04.13.2016 Hospira Issues A Voluntary Recall For One Lot Of 50% Magnesium Sulfate Injection, USP Due To The Presence Of Particulate03.23.2016 Hospira Issues A Voluntary Recall For One Lot Of Sodium Bicarbonate Injection, USP Due To The Presence Of A Particulate01.05.2016 HOSPIRA ISSUES A VOLUNTARY NATIONWIDE RECALL OF ONE LOT OF MAGNESIUM SULFATE IN WATER FOR INJECTION DUE TO INCORRECT BARCODE LABELING ON THE PRIMARY CONTAINER10.28.2015 Pfizer Joins Broad Effort to Observe National Disability Employment Awareness Month10.13.2015 Pfizer Expands Support for Patients with Gaucher Disease Through New Agreement for ELELYSO07.17.2015 FDA Accepted For Review Pfizer NDA for ADHD Treatment07.10.2015 Pfizer Applauds House of Representatives for Passing the 21st Century Cures Act06.11.2015 Pfizer Wins Jury Verdict in Zoloft Case in Philadelphia05.21.2015 Pfizer Applauds the Committee on Energy and Commerce for Passing the 21st Century Cures Act Today04.30.2015 Pfizer Praises Passage Of New Alabama Legislation10.16.2014 Statement Regarding FDA Advisory Committees’ Vote on CHANTIX®05.07.2014The Benefits of a Potential Combination with AstraZeneca PLC ("AstraZeneca")02.06.2014 U.S. Appeals Court Upholds Lyrica Patent That Expires On December 30, 201810.07.2013 Bridget Walsh Appointed Vice President of Federal Government Relations09.25.2013 Pfizer subsidiary Meridian awarded government contract to develop auto-injector medical countermeasure against nerve agent exposure07.24.2013 Pfizer Statement on PhRMA-EFPIA Principles for Responsible Clinical Trial Data SharingPaginationFirst page« FirstPrevious page‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsScience Will WinThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesOur ProductsShot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled…Our ProductsShot of a Lifetime: How Pfizer Developed its Own Raw Materials…Our ProductsShot of a Lifetime: How Pfizer and BioNTech Developed and…Our ProductsShot of a Lifetime: How Pfizer is Partnering with CMOs to…Your HealthWhy Raising Health Literate Children Is ImportantOur PurposeReasons to Reject H.R. 3Your HealthThe Truth About COVID-19 and Black FungusOur ScienceContinuing to Follow the Science: An Open Letter from Pfizer…Our PurposeHow We’re Partnering to Improve Health Outcomes for Black YouthOur PurposeWhy Foreign Drug Pricing Policies Don’t WorkOur PeopleRamcess Jean-Louis Is Ready to Build on Pfizer’s Longtime…Our PurposeThrough Public-Private Partnership, Scientists are Working to…Our PurposeAiming for Equity: Assessing Pfizer's Ongoing Commitment to…Our PeopleThanking John Young for His Years of Service to Pfizer – and to…Our PurposeIncreased Access to Biosimilars Could Save the U.S. Healthcare…Your HealthTranslating Technical Language into Plain Language for Clinical…Our PurposeHow 10 Biopharma Companies are Working Together to Bring…Our PeopleView for the FutureYour HealthA "Ticklist" For Staying Safe While Spending Time…Your HealthHealth Screenings Every African American Man Should KnowYour HealthEmpowering Patients by Closing the Health Literacy GapShowHide
![iStock-1199449498_380x300[1].jpg](https://cdn.pfizer.com/pfizercom/styles/style_300_170/s3/2021-09/iStock-1199449498_380x300%5B1%5D.jpg?pYyJpQdhyvaU22v13JPyau8ro2rGk0CR&itok=pJGCW7Vt)
